We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Haemonetics Corp | NYSE:HAE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.58 | 0.62% | 93.91 | 94.63 | 93.09 | 94.52 | 154,766 | 18:41:51 |
BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time.
The public may access Mr. Simon's presentation live via webcast at: https://jpmorgan.metameetings.net/events/healthcare19/sessions/23877-haemonetics-corporation/webcast
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.
INVESTOR CONTACTS: | MEDIA CONTACT: |
Gerry Gould, VP-Investor Relations | Carla Burigatto, VP-Communications |
(781) 356-9402 | (781) 348-7263 |
gerry.gould@haemonetics.com | carla.burigatto@haemonetics.com |
Olga Vlasova, Sr. Mgr.-Investor Relations | |
(781) 356-9763 | |
olga.vlasova@haemonetics.com |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-37th-annual-jp-morgan-healthcare-conference-300769142.html
SOURCE Haemonetics Corporation
Copyright 2018 PR Newswire
1 Year Haemonetics Chart |
1 Month Haemonetics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions